Free Trial

VolitionRx (VNRX) SEC Filings & 10K Form

$0.68
-0.05 (-6.85%)
(As of 05/28/2024 ET)

Recent VolitionRx SEC Filings

DateFilerForm TypeView
05/24/2024
3:05 PM
Retter Andrew (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
3:07 PM
Butera Salvatore Thomas (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
10:14 AM
VolitionRx (Filer)
Form D
Notice of Exempt Offering of Securities 
03/25/2024
3:19 PM
VolitionRx (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/19/2024
3:37 PM
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/26/2024
3:01 PM
Futcher Edward (Reporting)
VolitionRx (Issuer)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
3:01 PM
Reynolds Cameron John (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
3:01 PM
Colman Alan (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
3:02 PM
Batchelor Ann-Louise (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
3:02 PM
Hughes Terig (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
3:02 PM
Butera Salvatore Thomas (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
3:03 PM
Rootsaert Rodney Gerard (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
3:03 PM
Barnes Phillip (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
9:41 AM
Eight Corp Ltd (Reporting)
Hever Investments Ltd (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
7:00 AM
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2023
9:31 AM
Eight Corp Ltd (Reporting)
Hever Investments Ltd (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
9:59 AM
Butera Salvatore Thomas (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
8:38 AM
Butera Salvatore Thomas (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
8:11 AM
Rootsaert Rodney Gerard (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
7:51 AM
Reynolds Cameron John (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
7:07 AM
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2023
8:39 AM
Futcher Edward (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2023
8:39 AM
Innes Guy Archibald (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2023
9:28 AM
Innes Guy Archibald (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2023
10:06 AM
Innes Guy Archibald (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
9:01 AM
Butera Salvatore Thomas (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2023
3:16 PM
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/20/2023
3:02 PM
Reynolds Cameron John (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/20/2023
3:05 PM
Hughes Terig (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
3:05 PM
Forterre Gael (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
3:05 PM
Michel Gaetan (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
3:05 PM
Faulkes Martin Charles (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
3:06 PM
Butera Salvatore Thomas (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
9:01 AM
Barnes Phillip (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
8:41 AM
Faulkes Martin Charles (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2023
8:35 AM
Micallef Jacob Vincent (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2023
9:07 AM
Micallef Jacob Vincent (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
10:49 AM
Futcher Edward (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
10:49 AM
Kway Jasmine (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2023
11:00 AM
Michel Gaetan (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2023
8:40 AM
Butera Salvatore Thomas (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)

Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.

Click here if you’d like to learn more about these five cryptos…
08/16/2023
11:28 AM
Reynolds Cameron John (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
3:31 PM
VolitionRx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2023
3:18 PM
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2023
3:57 PM
VolitionRx (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/06/2023
9:14 AM
Butera Salvatore Thomas (Reporting)
VolitionRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
8:56 PM
VolitionRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2023
3:56 PM
VolitionRx (Filer)
Form 424B5
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:VNRX) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners